Home » Topics » Endocrine/metabolic, BioWorld Science

Endocrine/metabolic, BioWorld Science
RSS

Phase I results reported for Cortecs' oral insulin

July 7, 1997

Proteoglycan synthesis increased by rhBMP-2

July 7, 1997

SmithKline Beecham and Nycomed disclose hemoregulatory compounds

July 7, 1997

Pharmacia & Upjohn discloses agents for diabetes

July 7, 1997

Low serum cholesterol levels increase risk of suicide in certain psychiatric disorders

July 4, 1997

Icos PDE V inhibitor in phase I trials

July 4, 1997

Exocell presents new small-molecule antiglycation agent

July 4, 1997

Rebamipide for diabetic nephropathy

July 3, 1997

Edex cleared for erectile dysfunction in the U.S.

July 2, 1997

Injectable microsphere-encapsulated norethindrone is a safe and effective contraceptive

July 2, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 5, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...